Cipla to pick 14.6% stake in Chase Pharmaceuticals for $1.5m

Drug firm Cipla Ltd today said it will acquire 14.6 per cent stake in US-based Chase Pharmaceuticals Corporation Inc for USD 1.5 million.

The investment will be done through Cipla's wholly owned subsidiary Cipla (EU) Ltd, UK.

Cipla also said it will make an additional USD 4.5 million investment in Chase upon achievement of certain milestones.

"..Company has signed a definitive agreement to invest USD 1.5 million in Chase Pharmaceuticals Corporation Inc, US, to acquire 14.6 per cent stake in Chase on a fully diluted basis," Cipla said in a BSE filing.

Chase is an early stage drug development company, engaged in novel approaches to improve treatments for Alzheimer's disease.

Post new comment

E-mail ID will not be published
CAPTCHA
This question is for testing whether you are a human visitor and to prevent automated spam submissions.

EDITORIAL OF THE DAY

  • For those who are left to survive a war-torn world, let there be peace

    The hunger games have begun, and they have started reaping our children. There is no way around it.

FC NEWSLETTER

Stay informed on our latest news!

INTERVIEWS

GV Nageswara Rao

MD & CEO, IDBI Federal Life

Timothy Moe

Goldman Sachs

Chander Mohan Sethi

CMD, Reckitt Benckiser India

COLUMNIST

Urs Schöttli

Shifting sands in the Far East

As was to be expected, Japanese prime minister Shinzo Abe ...

Zehra Naqvi

When humanity died, bestiality prevailed

The terrorist attack that killed 132 children in Peshawar has ...

Bubbles Sabharwal

Why self-esteem must be your best friend forever

Two negatives do make a positive! Imagine no doubts, no ...

INTERVIEWS

William D. Green

Chairman & CEO, Accenture